Search
Last week, we brought you part one of our interview with Martin VanTrieste, vice president of quality assurance at Amgen, a biotechnology company, and the co-founder of Rx-360, a global consortium formed to address weaknesses in the pharmaceutical supply chain. Now we bring you the conclusion of our interview. PSM: It might surprise some that while a medication is manufactured…
Read MoreFrom drug manufacturing to delivery, weaknesses in the pharmaceutical supply chain have been long documented—and introduce opportunities for substandard and counterfeit medications to be passed along to consumers. To mitigate this global threat, a group of companies and associations from all facets of the pharmaceutical industry have teamed up to form Rx-360, an international consortium aimed at securing the performance…
Read MoreBACKGROUND: The applications of radio frequency identification (RFID) technology carry a tremendous potential for pharmaceutical industry. There is a pressing need to analyze the performance of RFID tags attached to various pharmaceutical dosage forms. METHOD: The readability of RFID-tagged pharmaceutical products is, for the first time, systematically investigated by experiments. Factors considered include dosage forms, ion concentration in solution, angle…
Read MoreThe Partnership for Safe Medicines (PSM) has long reported on the growing issue of pharmaceutical spam advertising—and now SophosLab Canada has taken a closer look at the solicitation of counterfeit products online.
Read MoreThis is concludes our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company, on the subjects of counterfeit drugs sold online, search engine advertising what’s needed from regulators to protect Web users. PSM: FDA is preparing to receive public remarks regarding the online promotion of medical products and adverse event reporting. What recommendations will you/have you given? GB:…
Read MoreThe Partnership for Safe Medicines (PSM) issued the following statement regarding the International Internet Week of Action, code named Operation Pangea II, intended to curb illegal actions involving medical products. PSM is a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines.
Read MoreThis is part four of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 | Part 3 PSM: In your estimation, how many…
Read MoreThis is part three of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 PSM: What steps have search engines like Google and…
Read MoreIt was a cringe-worthy moment for China when 600 000 counterfeit antimalarial tablets were intercepted by the Nigerian government in June. Produced and shipped from China, they bore an unexpected label: "Made in India." Even the fakes were being faked. It was a new low. Many things are faked in China —from Gucci sunglasses to iPhones. Drugs are no exception.…
Read MoreThis is part two of an interview with Garth Bruen, the co-founder of KnujOn, an internet compliance company, on the KnujOn system, search engine advertising and what’s needed from regulatory agencies to protect consumers from counterfeit medical products advertised online. Read part one of our interview. PSM: Have you noticed an uptick in the number of Web users receiving or…
Read More